Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 27 January 2026 - 12:36

Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Date of authorisation: 09/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 27 January 2026 - 11:10

Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 27 January 2026 - 10:30

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 18, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness